DOFI
DCVC Opportunity Fund II Portfolio holdings
AUM
$115M
This Quarter Return
+81.95%
1 Year Return
+402%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+41%)
Cap. Flow
-$25.9M
Cap. Flow
% of AUM
-22.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Rocket Lab Corporation Common Stock
RKLB
|
$25.9M |
Sector Composition
| 1 | Industrials | 82.65% |
| 2 | Healthcare | 17.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Rocket Lab Corporation Common Stock
RKLB
$23.4B
| $95.3M | 82.65% | 2,663,139 -725,110 | -21% | -$25.9M |
|
2
Recursion Pharmaceuticals
RXRX
$2.04B
| $20M | 17.35% | 3,951,141 | – | – |
|